NCT06850025 Heat Waves, Urban Heat Islands, and Wellbeing and Health: a Mobile Sensing Approach
| NCT ID | NCT06850025 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut National de la Santé Et de la Recherche Médicale, France |
| Condition | General Population, no Specific Condition |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2025-02-25 |
| Primary Completion | 2027-02-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2025-02-25 with a primary completion date of 2027-02-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The first objective of H3Sensing is to investigate outdoor environmental, building, dwelling, situational, and behavioral determinants of objectively assessed personal heat stress over daily movements during warm periods. The second aim is to investigate how these heat stress determinants and momentary and cumulated heat stress itself are related to physiological indicators of heat stress, sleep, thermal discomfort, and well-being.
Eligibility Criteria
Inclusion Criteria: * Person aged between 30-64 years * Person living in the Ile-de-France Exclusion Criteria: * Person subject to a legal protection measure (safeguarding of justice, curatorship, guardianship) * Person deprived of liberty by a judicial or administrative decision, * Person with a major functional limitation affecting their spatial mobility * Person unable to complete a questionnaire * Known cardiovascular (other than hypertension) or cerebrovascular disease: personal history of myocardial infarction, rhythm disorders or stroke * People wearing a pacemaker or other implanted device, due to the risk of interference * Pregnant or breastfeeding woman * Person working night or shift * Person with a definite plan to move in the coming months (before the second collection during summer) * Person who initially refuses to participate in this second wave of the study * Person working outside the Ile de France
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06850025 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 64 Years, studying General Population, no Specific Condition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06850025 currently recruiting?
Yes, NCT06850025 is actively recruiting participants. Contact the research team at basile.chaix@iplesp.upmc.fr for enrollment information.
Where is the NCT06850025 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT06850025 clinical trial?
NCT06850025 is sponsored by Institut National de la Santé Et de la Recherche Médicale, France. The trial plans to enroll 180 participants.